Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: Anti-cyclic citrullinated peptide (anti-CCP) auto-antibodies (auto-Abs) represent the current gold standard for the diagnosis of rheumatoid arthritis (RA). However, growing evidence suggests that a variety of other citrullinated or not citrullinated self-proteins may act as autoantigens and lead to the production of auto-Abs. The identification of diagnostic and/or prognostic value of such novel auto-Abs is under intense investigation. We recently demonstrated that RA patients display higher prevalence of auto-Abs against the interferon-inducible protein 16 (anti-IFI16) but these auto-Abs do not have a good diagnostic value (1). Recent data showed that auto-Abs against citrullinated alpha-enolase (anti-CEP1) are associated with erosive RA (2). The purpose of this study was to investigate the possible prognostic value of anti-CEP-1 and anti-IFI16 as well as the clinical implication of their association with anti-CCP in a cohort or RA patients.
Methods: Two-hundred and fifty-two RA patients were enrolled and serum samples were obtained. Auto-Abs were assessed as follows: anti-CCP EDIA 2nd generation ELISA kit (Eurodiagnostica); anti-CEP-1 IgG ELISA kit (Euroimmun). In a subgroup of 113 patients also anti-IFI16 auto-Abs were assessed with an in-house ELISA kit (1). Clinical and serological records of patients were collected and statistical analysis was performed with SPSS 21.0 software.
Results: One hundred and twenty patients (44%) displayed anti-CEP-1 and, among these, 97 patients (87%) also displayed anti-CCP. Logistic regression analysis revealed an association between both auto-Abs and RA-associated pulmonary disease (odds ratio-OR=2.9; 95%CI= 1.06-7.9; p=0.04). We also confirmed that anti-CEP-1 are associated with erosive RA, but, of interest, to a greater extent compared to anti-CCP (anti-CEP-1: OR=4.12; p=0.04; anti-CCP: OR=2.1; p=0.03). The analysis that included anti-IFI16 revealed that a small proportion of patients display all the three auto-Abs (9%), but the triple positivity was significantly associated with male gender (OR=3.5; p=0.02), the presence of rheumatoid nodules (OR=5,3; p=0.015) and pulmonary involvement (OR=2,6; p=0.007). Anti-IFI16 were associated to male gender independently of the presence of the other two auto-Abs.
Conclusion: Our study suggests that anti-CEP-1 auto-Abs may participate to the development of RA-associated pulmonary manifestation together with anti-CCP and that the assessment of multiple auto-Abs in daily practice may help clinician to stratify RA patients in order to identify those at higher risk to develop extra-articular manifestations. References 1-Alunno A et al. Arthritis Care Res 2016;68:440-5 2-Fisher BA et al. Ann Rheum Dis 2011;70:1095-1098
To cite this abstract in AMA style:Alunno A, Bistoni O, Pratesi F, Caneparo V, Topini F, Puxeddu I, De Andrea M, Landolfo S, Migliorini P, Gerli R. Clinical Significance of Multiple Autoantibody Specificities in Rheumatoid Arthritis: The Role of Anti-Citrullinated Alpha-Enolase and Anti-Interferon Inducible Protein 16 Antibodies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-significance-of-multiple-autoantibody-specificities-in-rheumatoid-arthritis-the-role-of-anti-citrullinated-alpha-enolase-and-anti-interferon-inducible-protein-16-antibodies/. Accessed November 26, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-significance-of-multiple-autoantibody-specificities-in-rheumatoid-arthritis-the-role-of-anti-citrullinated-alpha-enolase-and-anti-interferon-inducible-protein-16-antibodies/